Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept plus mycophenolate mofetil in lupus nephritis
2007-004518-15Phase 3Terminated
- Sponsor
- Merck Serono
- Start
- Dec 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lupus nephritis (LN) comparing Atacicept + mycophenolate mofetil with Placebo + mycophenolate mofetil (2 arms). Primary endpoint: Renal response at Week 52. Started Dec 2007; status: terminated.
02
Drugs
atacicept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2007-004518-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004518-15.